Aurora Financial JournalNovo Nordisk A/S (NVO)
NYSE · Health care · Pharmaceutical Preparations · Financial statements, TTM figures and earnings dates
In fiscal year 2025 (ended December 31, 2025), Novo Nordisk A/S reported revenue of DKK 309.06B and net income of DKK 102.43B. Annual financial statements are available for fiscal years 2019 to 2025, taken from the company's filings with the SEC.
Open interactive financials →Key financials
| DKK | FY2025 2025-12-31 | FY2024 2024-12-31 | FY2023 2023-12-31 | FY2022 2022-12-31 | FY2021 2021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | DKK 309.06B | DKK 290.40B | DKK 232.26B | DKK 176.95B | DKK 140.80B |
| Gross profit | DKK 250.28B | DKK 245.88B | DKK 196.50B | DKK 148.51B | DKK 117.14B |
| Operating income | DKK 127.66B | DKK 128.34B | DKK 102.57B | DKK 74.81B | DKK 58.64B |
| Net income | DKK 102.43B | DKK 100.99B | DKK 83.68B | DKK 55.52B | DKK 47.76B |
| Diluted EPS | DKK 23.03 | DKK 22.63 | DKK 18.62 | DKK 12.22 | DKK 10.37 |
| Cash flow | |||||
| Operating cash flow | DKK 119.10B | DKK 120.97B | DKK 108.91B | DKK 78.89B | DKK 55.00B |
| Capital expenditure | DKK 60.14B | DKK 47.16B | DKK 25.81B | DKK 12.15B | DKK 6.33B |
| Free cash flow | DKK 58.96B | DKK 73.80B | DKK 83.10B | DKK 66.74B | DKK 48.66B |
| Balance sheet | |||||
| Cash and equivalents | DKK 26.46B | DKK 15.65B | DKK 14.39B | DKK 12.65B | DKK 10.72B |
| Total assets | DKK 542.90B | DKK 465.63B | DKK 314.49B | DKK 241.26B | DKK 194.51B |
| Total liabilities | DKK 348.86B | DKK 322.14B | DKK 207.93B | DKK 157.77B | DKK 123.76B |
| Total debt | DKK 130.96B | DKK 102.79B | DKK 27.01B | DKK 25.78B | DKK 26.64B |
| Shareholders' equity | DKK 194.05B | DKK 143.49B | DKK 106.56B | DKK 83.49B | DKK 70.75B |
TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in DKK as reported; per-share data adjusted for stock splits.
Annual reports
More on the interactive page
The full NVO page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, the statements exactly as filed with the SEC, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.
Open NVO financials →